Surgical Treatment of Bartholin's Gland Abscess: Is Word Catheter Superior to Marsupialization?
Cultures
Surgical management
Word catheter application
Journal
Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
05
11
2020
revised:
10
12
2020
accepted:
09
01
2021
pubmed:
19
1
2021
medline:
18
9
2021
entrez:
18
1
2021
Statut:
ppublish
Résumé
Bartholin's gland abscess may occur in up to 2% of the women. Surgical drainage using the Word catheter application or marsupialization is the treatment of choice in the management of Bartholin's gland abscess. We aimed to compare the abscess recurrence rates between these 2 surgical methods. A retrospective cohort database study. A university-affiliated, high-volume teaching hospital in southern Israel. All women who were surgically treated for Bartholin's gland abscess. Different clinical and postoperative characteristics were retrieved from the patients' records. A univariate analysis was conducted, and p <.05 was considered significant. During the study period, 321 women were admitted to our center with Bartholin's gland abscess and were managed surgically. Of these, 215 (67%) were treated using the Word catheter and 106 (33%) by drainage and marsupialization. No differences were found in clinical and microbiologic features between the study groups. In addition, recurrence rates as well as recurrent admissions did not differ significantly. Postoperative complications were similar between the groups. Our study reassures that both the Word catheter application and marsupialization are appropriate and safe when treating Bartholin's gland abscess.
Identifiants
pubmed: 33460773
pii: S1553-4650(21)00034-0
doi: 10.1016/j.jmig.2021.01.006
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1211-1215Informations de copyright
Copyright © 2021 AAGL. Published by Elsevier Inc. All rights reserved.